Encompass Health (NYSE:EHC) EVP Sells $1,121,710.70 in Stock

Posted by Stanley Muller on Aug 14th, 2026

Encompass Health Corporation (NYSE:EHC – Get Free Report) EVP John Patrick Darby sold 8,906 shares of Encompass Health stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.95, for a total value of $1,121,710.70. Following the completion of the transaction, the executive vice president owned 75,041 shares of the company’s stock, valued at $9,451,413.95. This trade represents a 10.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Encompass Health Stock Performance

Encompass Health stock opened at $123.44 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.17. Encompass Health Corporation has a 12 month low of $92.77 and a 12 month high of $127.99. The company has a fifty day moving average price of $108.73 and a two-hundred day moving average price of $105.34. The company has a market cap of $12.18 billion, a PE ratio of 20.10, a P/E/G ratio of 2.53 and a beta of 0.72.

Encompass Health (NYSE:EHC – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter last year, the business posted $1.40 EPS. The business’s revenue was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Research analysts expect that Encompass Health Corporation will post 6.08 earnings per share for the current year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a $0.21 dividend. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is 12.38%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Truist Financial raised their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, August 7th. Weiss Ratings raised Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday. Barclays boosted their price target on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Leerink Partners set a $152.00 price objective on shares of Encompass Health in a research report on Friday, May 22nd. Finally, Wall Street Zen downgraded shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $148.71.

Read Our Latest Stock Analysis on EHC

Institutional Trading of Encompass Health

Several hedge funds and other institutional investors have recently modified their holdings of the business. Royal Bank of Canada boosted its position in Encompass Health by 21.5% during the 1st quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after acquiring an additional 15,677 shares during the period. Millennium Management LLC lifted its position in shares of Encompass Health by 38.4% in the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after purchasing an additional 25,574 shares in the last quarter. Caxton Associates LLP acquired a new stake in shares of Encompass Health during the first quarter worth approximately $259,000. Walleye Capital LLC boosted its holdings in shares of Encompass Health by 667.6% during the second quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock worth $800,000 after purchasing an additional 7,671 shares during the period. Finally, Gamco Investors INC. ET AL purchased a new position in Encompass Health during the second quarter valued at approximately $588,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

(Get Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.